IUC25693-90 Real-world effectiveness of pembrolizumab plus axitinib in metastatic renal cell carcinoma in Panama
Abstract Background To evaluate the effectiveness and safety of pembrolizumab plus axitinib as first-line therapy for metastatic renal cell carcinoma (mRCC) in a national real-world cohort. This study is the first from Panama and the first from Central America to address this treatment strategy. Methods We conducted a...